STXS - Robotic Systems for MedicineStereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. The
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.30 USD
−24.05 M USD
26.92 M USD
70.54 M
About Stereotaxis, Inc.
Sector
Industry
CEO
David Leo Fischel
Website
Headquarters
St. Louis
Founded
1990
FIGI
BBG000PSJBC2
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
5/13/24 - $stxs - beware if you blindly own this; downside > up5/13/24 - vrockstar - incredibly lump results, and surprising stock remains bid even after the last two whiffs (big whiffs too). cool tech. would like to see this win, but burning 10 mm a year w/ 20 mm in the bank, some complications in the stack and overall worth north of $150 mm... is a tough one
Stereotaxis; I am not a financial analyst, not a stock analyst, not even a robot analyst. This is my opinion, and you should do research on anything you put money into, and my ramblings are not that research.
With that said, this is my personal take on this little company that builds robots that do heart surger
$STXS can rise in the next daysContextual immersion trading strategy idea.
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease in the United States and internationally
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of STXS is 1.76 USD — it has increased by 6.02% in the past 24 hours. Watch Stereotaxis, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Stereotaxis, Inc. stocks are traded under the ticker STXS.
STXS stock has risen by 11.39% compared to the previous week, the month change is a −1.68% fall, over the last year Stereotaxis, Inc. has showed a −39.31% decrease.
We've gathered analysts' opinions on Stereotaxis, Inc. future price: according to them, STXS price has a max estimate of 5.00 USD and a min estimate of 4.00 USD. Watch STXS chart and read a more detailed Stereotaxis, Inc. stock forecast: see what analysts think of Stereotaxis, Inc. and suggest that you do with its stocks.
STXS reached its all-time high on Oct 29, 2007 with the price of 168.80 USD, and its all-time low was 0.47 USD and was reached on Nov 15, 2016. View more price dynamics on STXS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
STXS stock is 7.19% volatile and has beta coefficient of 0.58. Track Stereotaxis, Inc. stock price on the chart and check out the list of the most volatile stocks — is Stereotaxis, Inc. there?
Today Stereotaxis, Inc. has the market capitalization of 151.32 M, it has decreased by −2.34% over the last week.
Yes, you can track Stereotaxis, Inc. financials in yearly and quarterly reports right on TradingView.
Stereotaxis, Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
STXS earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.07 USD resulting in a −38.46% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Stereotaxis, Inc. earnings.
Stereotaxis, Inc. revenue for the last quarter amounts to 6.34 M USD, despite the estimated figure of 7.08 M USD. In the next quarter, revenue is expected to reach 6.88 M USD.
STXS net income for the last quarter is −7.51 M USD, while the quarter before that showed −6.19 M USD of net income which accounts for −21.41% change. Track more Stereotaxis, Inc. financial stats to get the full picture.
No, STXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 139 employees. See our rating of the largest employees — is Stereotaxis, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Stereotaxis, Inc. EBITDA is −23.77 M USD, and current EBITDA margin is −88.31%. See more stats in Stereotaxis, Inc. financial statements.
Like other stocks, STXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stereotaxis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stereotaxis, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stereotaxis, Inc. stock shows the sell signal. See more of Stereotaxis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.